Evidence map›Paper›PMID 40043065›Full record

ArticlePLoS pathogens2025

The CXCR6-CXCL16 axis mediates T cell control of polyomavirus infection in the kidney.

Matthew D Lauver, Zoe E Katz, Havell Markus, Nicole M Derosia, Ge Jin, Katelyn N Ayers, Arrienne B Butic, Kaitlyn Bushey, Catherine S Abendroth, Dajiang J Liu and 1 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. β-oxidation-mediated differentiation of effector CD4Journal of neuroinflammation · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Matthew D LauverDepartment of Microbiology and Immunology, Penn State College of Medicine, Hershey, Pennsylvania, United States of America.
Zoe E KatzDepartment of Microbiology and Immunology, Penn State College of Medicine, Hershey, Pennsylvania, United States of America.
Havell MarkusDepartment of Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania, United States of America.
Nicole M DerosiaDepartment of Microbiology and Immunology, Penn State College of Medicine, Hershey, Pennsylvania, United States of America.
Ge JinDepartment of Microbiology and Immunology, Penn State College of Medicine, Hershey, Pennsylvania, United States of America.
Katelyn N AyersDepartment of Microbiology and Immunology, Penn State College of Medicine, Hershey, Pennsylvania, United States of America.
Arrienne B ButicDepartment of Microbiology and Immunology, Penn State College of Medicine, Hershey, Pennsylvania, United States of America.
Kaitlyn BusheyBio X Cell, Inc., Lebanon, New Hampshire, United States of America.
Catherine S AbendrothDepartment of Pathology, Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States of America.
Dajiang J LiuDepartment of Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania, United States of America.
Aron E LukacherDepartment of Microbiology and Immunology, Penn State College of Medicine, Hershey, Pennsylvania, United States of America.ORCID 0000-0002-7969-2841

Funding

Deciphering Early Stages of Polyomavirus CNS Pathogenesis and ImmunityR35NS127217 · NINDS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI Aron Eliot Lukacher · 2022 to 2026
$4.4M
Methods to unveil sex-specific genetic architecture in trans-ancestry meta-analysisR01HG011035 · NHGRI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI Bibo Jiang · 2022 to 2026
$3.8M
Integrative approaches to understand systemic lupus erythematosus etiology in trans-ancestry genetic studiesR01AI174108 · NIAID · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI Laura Carrel, Dajiang Liu · 2022 to 2026
$2.8M
Computation, Bioinformatics, and Statistics (CBIOS) Training ProgramT32GM102057 · NIGMS · PENNSYLVANIA STATE UNIVERSITY, THE · PI CHIAROMONTE, FRANCESCA, GIRIRAJAN, SANTHOSH · 2013 to 2022
$2.7M
Integrative genomic and geospatial analysis of insurance claim, biobank and GWAS summary statistics for complex traitsR01ES036042 · NIEHS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI Bibo Jiang · 2023 to 2026
$2.1M
Genetic regulation of genes on active and inactive X chromosome and their contribution to sex-biased diseasesF30GM151848 · NIGMS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI MARKUS, HAVELL · 2023 to 2024
$69k
NHGRI NIH HHS R01 HG011035NIAID NIH HHS R01 AI174108NIEHS NIH HHS R01 ES036042NIGMS NIH HHS F30 GM151848NIGMS NIH HHS T32 GM102057NINDS NIH HHS R35 NS127217
6 · The paper itself

Abstract

BK polyomavirus (PyV) establishes lifelong asymptomatic infections in the reno-urinary system of most humans. BKPyV-associated nephropathy is the leading infectious cause of kidney allograft loss. Using mouse PyV, a natural murine pathogen that also persists in the kidney, we define a dominant chemokine receptor-chemokine axis that directs T cell infiltration of the kidney. We found that CXCR6 was required for CD4+ and CD8+ T cells to be recruited to and retained in the kidney, respectively. Absence of CXCR6 impaired virus control in the kidney. The soluble form of CXCL16 was increased in kidneys of infected mice and in vivo CXCL16 neutralization reduced numbers of virus-specific CD8+ T cells infiltrating the kidney. In vivo administration of IL-12 upregulated CXCR6 expression on virus-specific CD8+ T cells, improved T cell recruitment to the infected kidney, and reduced virus levels. Notably, T cells in kidney biopsies from PyV-associated nephropathy patients express CXCR6 and transcriptional analysis shows significant upregulation of CXCR6 and CXCL16. These findings demonstrate the importance of the CXCR6-CXCL16 axis in regulating T cell responses in the kidney to PyV infection.

Indexed as

BK VirusCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesChemokines, CXCKidneyKidney DiseasesPolyomavirus InfectionsReceptors, ChemokineReceptors, ScavengerReceptors, VirusTumor Virus InfectionsAnimalsChemokine CXCL16HumansMiceMice, Inbred C57BLChemokine CXCL16Chemokines, CXCCXCL16 protein, humanCxcl16 protein, mouseCXCR6 protein, humanCxcr6 protein, mouseReceptors, ChemokineReceptors, CXCR6Receptors, ScavengerReceptors, Virus

Identifiers

PMID40043065
PMCPMC11922244

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.